Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Vedanta Aluminium, Adani Power, 4 other stocks with up to 24% upside. Do you own any?
Several brokerages have initiated coverage on Indian stocks, forecasting significant upside potential. Vedanta Aluminium and Adani Power are among the companies with positive outlooks. Uno Minda and Blue Star also show strong growth prospects for investors. Aequs and Aditya Infotech are highlighted for their manufacturing and market leadership. These selections offer investors potential gains based on analyst recommendations.
Stock Market Today Live, July 9: Sensex up 450 pts, trades at 76,956.50; Nifty up 155 pts; Sun Pharma, SBI Life, Bajaj Finserv top gainers - BusinessLine
Stock Market Today Live, July 9: Sensex up 450 pts, trades at 76,956.50; Nifty up 155 pts; Sun Pharma, SBI Life, Bajaj Finserv top gainersBusinessLine
Pharma stocks: Lupin, Torrent hit new peaks; Sun nears summit; here's why
Pharma stock rally: Orchid Pharma, Hikal, Unichem Labs, IOL Chemicals, SPARC, RPG Life Sciences and Acutaas Chemicals surged up to 13% in Wednesday's trade.
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection
The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its tissue of origin from a single blood sample.
Poly Medicure among 4 stocks that closed below VWAP
Four Nifty500 stocks, Poly Medicure, Aditya Birla Real Estate, Siemens Energy India, and Onesource Specialty Pharma, closed over 2% below their VWAP on July 3, indicating potential bearish momentum and heightened selling pressure, according to technical scan data.
Sun Pharma secures relief in 'Pantocid' trademark dispute
Delhi High Court has halted Ahmedabad-based Finecure Pharmaceuticals from producing and selling drugs with names similar to Sun Pharma's 'Pantocid'. The court permitted Finecure to sell existing stock of 'Pantopacid' within four months, provided an affidavit detailing the inventory is filed. This decision overturns a previous ruling that had refused to grant an injunction against Finecure, highlighting significant sales disparities between the two companies.
Sun Pharma to acquire Innovcare Lifesciences for ₹271.2 crore
Acquisition of the Mumbai-based pharma, nutraceutical and cosmeceutical products company is aimed at strengthening Sun Pharma’s product portfolio.
Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transaction
India's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash deal. This strategic move aims to bolster Sun Pharma's product offerings. Innovcare, which markets pharmaceutical drugs, nutraceuticals, and cosmeceuticals, reported steady revenue growth in recent fiscal years. The transaction, expected to conclude by July 2026, is a significant step for Sun Pharma's expansion.
Hindalco appoints Kapil Agrawal as CEO (Designate) for copper business; Rohit Pathak to move to new role
Hindalco Industries has appointed Kapil Agrawal as CEO (Designate) – Copper with effect from November 1, 2026. He will take over as CEO of the Copper business from March 1, 2027, succeeding Rohit Pathak, who will transition to a new role within the Aditya Birla Group.
Nifty tops 23,850 as oil slump sparks broad-based rally
The key equity benchmark indices extended gains for a second consecutive session on Monday, supported by a sharp decline in crude oil prices and optimism surrounding a US-Iran peace agreement. Buying was broad-based, with most sectoral indices ending in the green. Investor sentiment was further buoyed by strong global cues, a stronger rupee and easing market volatility. The Nifty settled above the 23,850 mark, led by gains in consumer durables and auto stocks. However, pharma and healthcare shares bucked the trend and closed lower.
INR surges amid sharp pull back in oil prices; Sensex and Nifty jump by around 2%
The Indian rupee surged 67 paise to close at 95.18 (provisional) against the greenback on Friday as global oil prices fell sharply after US President Donald Trump indicated an imminent deal with Iran. A firm trend in domestic equity markets and a weaker American currency also supported the rupee during the day. Indian shares closed Friday's session on a buoyant note in a broad-based rally, with both frontline and broader market indexes posting sharp gains. The BSE Sensex settled at 75,527.95, surging 1,695.40 points (2.30%), and the NSE Nifty50 ended at 23,622.90, climbing 461.30 points (1.99%). Trump has reportedly said a deal to end the war with Iran is nearly complete, and is expected to be signed over the weekend in Europe, as he called off military strikes on the Islamic Republic hours after threatening to take control of its oil industry.
AB Group reaffirms bet on Voda Idea with ₹4,730 Cr infusion
Vodafone Idea shareholders approved a ₹4,730-crore investment from the Aditya Birla Group via preferential allotment of warrants, increasing AB Group's stake to around 13%. Chairman Kumar Mangalam Birla stated the company's focus now shifts to execution across operations, customer service, and network expansion. This capital infusion will support capital expenditure and loan repayment, reinforcing Vi's financial health.